Standing Order
Kymera Therapeutics, Inc.

Dashboard

Kymera Therapeutics, Inc.

KYMRNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$9.1B
Price$110.5752w $37.68 – $119.35
Conviction3/ 5
Revenue (TTM)$51M
Revenue growth YoY-12.6%
P/E (trailing)
Gross margin100.0%
Operating margin-697.8%
Net margin-612.2%
52w price change+156.4%
Next earningsAug 10, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Jul 7
    Ownership changeSEC

    Form 4 filing reporting change in beneficial ownership.

  • Jul 2
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jul 2
    Ownership changeSEC

    SEC Form 4 insider ownership filing.

  • Jul 2
    Ownership changeSEC

    SEC Form 4 insider ownership filing.

  • Jun 30
    Ownership changeSEC

    SEC Form 4 insider transaction filing

  • Jun 30
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 30
    Trial initiationClinicalTrials.gov

    Phase 2 trial (NCT07217015) of KT-621 in moderate to severe atopic dermatitis updated to active, not recruiting.

  • Jun 30
    Trial initiationClinicalTrials.gov

    Phase 2 long-term extension study (NCT07677059) of KT-621 in asthma now recruiting participants.

  • Jun 29
    Trial initiationClinicalTrials.gov

    Kymera initiates Phase 2 trial (NCT07323654) of KT-621 in moderate to severe eosinophilic asthma; recruiting status.

  • Jun 26
    Ownership changeSEC

    SEC Form 4 insider ownership document filed

  • Jun 25
    Ownership changeSEC

    SEC Form 4 filing for change in beneficial ownership.

  • Jun 25
    Ownership changeSEC

    SEC Form 4 filing on change in beneficial ownership.

  • Jun 25
    OtherSEC

    8-K filing (items 7.01/8.01/9.01) on 2026-06-25

  • Jun 25
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 25
    Ownership changeSEC

    SEC Form 4 filing for insider transaction.

  • Jun 25
    Ownership changeSEC

    SEC Form 4 insider ownership change filing.

  • Jun 25
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 25
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 25
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Jun 25
    Ownership changeSEC

    SEC Form 4 insider ownership filing.

Not financial advice — research and opinion only. Disclosures